# Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia

> **NCT00417326** · PHASE2 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 174 (actual)

## Conditions studied

- Community-acquired Pneumonia

## Interventions

- **DRUG:** ONO-5046Na
- **DRUG:** ONO-5046Na

## Key facts

- **NCT ID:** NCT00417326
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-08
- **Final completion:** —
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00417326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00417326, "Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00417326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*